These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 19411240)
1. [Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors]. Duboeuf S; Flourié F; Courbil R; Oriol P; Benamara A; Chartier M; Rigal E; Garraud O Ann Biol Clin (Paris); 2009; 67(3):353-7. PubMed ID: 19411240 [TBL] [Abstract][Full Text] [Related]
2. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences]. Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273 [TBL] [Abstract][Full Text] [Related]
3. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163 [TBL] [Abstract][Full Text] [Related]
4. [Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis]. Chambost H Transfus Clin Biol; 2014 Nov; 21(4-5):210-5. PubMed ID: 25282489 [TBL] [Abstract][Full Text] [Related]
5. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization]. Mannessier L Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695 [TBL] [Abstract][Full Text] [Related]
6. Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003. Samama CM; Djoudi R; Lecompte T; Nathan-Denizot N; Schved JF; Can J Anaesth; 2005 Jan; 52(1):30-7. PubMed ID: 15625253 [TBL] [Abstract][Full Text] [Related]
7. [Anti-D sensitizations in the Leipzig District recorded in 1980 and 1981 and their relation to IgG-anti-D(Rh0) immunoprophylaxis]. Berge H Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):133-45. PubMed ID: 6192048 [TBL] [Abstract][Full Text] [Related]
8. Platelet transfusion and respecting patient D type. Cid J; Yazer MH; Lozano M Curr Opin Hematol; 2015 Nov; 22(6):540-6. PubMed ID: 26414185 [TBL] [Abstract][Full Text] [Related]
9. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611 [No Abstract] [Full Text] [Related]
10. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Cid J; Lozano M; Fernández-Avilés F; Carreras E; Pereira A; Mazzara R; Ordinas A Transfusion; 2006 Feb; 46(2):169-73. PubMed ID: 16441590 [TBL] [Abstract][Full Text] [Related]
11. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Lozano M; Cid J Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772 [TBL] [Abstract][Full Text] [Related]
12. RBC alloimmunization is an important complication of FFP transfusion: A case report of immune anti-D induced by apheresis fresh frozen plasma. Liu F; Zhou FY; Hu LH Transfus Clin Biol; 2009 Sep; 16(4):400-3. PubMed ID: 19748813 [TBL] [Abstract][Full Text] [Related]
13. D+ platelet transfusions in D- patients: cause for concern? Bartley AN; Carpenter JB; Berg MP Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725 [TBL] [Abstract][Full Text] [Related]
14. Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices. Lu W; Stephens L; Shmookler A; O'Brien K; Karp JK; Hermelin D; Bakhtary S; Almozain N; George M; Fung M Transfusion; 2024 May; 64(5):839-845. PubMed ID: 38534065 [TBL] [Abstract][Full Text] [Related]
15. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn]. Miquel E; Cavelier B; Bonneau JC; Rouger P Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293 [TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis. Haspel RL; Walsh L; Sloan SR Transfusion; 2004 May; 44(5):747-9. PubMed ID: 15104657 [TBL] [Abstract][Full Text] [Related]
17. Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles? Kitazawa J; Nollet K; Morioka H; Tanaka K; Inomata M; Kubuki Y; Ohto H Vox Sang; 2011 May; 100(4):395-400. PubMed ID: 21029111 [TBL] [Abstract][Full Text] [Related]
18. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. Cid J; Lozano M; Ziman A; West KA; O'Brien KL; Murphy MF; Wendel S; Vázquez A; Ortín X; Hervig TA; Delaney M; Flegel WA; Yazer MH; Br J Haematol; 2015 Feb; 168(4):598-603. PubMed ID: 25283094 [TBL] [Abstract][Full Text] [Related]
19. Prevention of Rh sensitization in the context of trauma: two case reports. Werch JB J Clin Apher; 2010; 25(2):70-3. PubMed ID: 20027640 [TBL] [Abstract][Full Text] [Related]
20. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients. Cid J; Lozano M Transfusion; 2005 Mar; 45(3):453; author reply 453-4. PubMed ID: 15752167 [No Abstract] [Full Text] [Related] [Next] [New Search]